Known hypersensitivity to the trial drugs or other contraindication to standard + induction chemotherapy
Known hypersensitivity to any of the study drugs
Prior hypersensitivity to any of the components of the study drugs
Part B only: Hypersensitivity to study drugs given in combination with LY
Known hypersensitivity to any of the components of the study drugs
Known hypersensitivity to any of the study drugs
Known hypersensitivity to any of the study drugs
Known hypersensitivity to any of the study drugs or analogs
Patients with known prior hypersensitivity reaction to any of the study drugs
Known hypersensitivity to any of the study drugs
Known hypersensitivity to the components of study drugs, its analogs, or drugs of similar chemical or biologic composition.
Known hypersensitivity to study drugs;
Known hypersensitivity to any of the study drugs or analogs
Patient has known hypersensitivity to the components of the study drugs or any analogs
Patient has known hypersensitivity to the components of the study drugs or their analogs
Known hypersensitivity to the study drugs or the drugs with similar chemical structures
Known hypersensitivity to the trial drugs (volasertib and romidepsin)
Known hypersensitivity to the components of study drugs, its analogs, or drugs of similar chemical or biologic composition
Patients with known hypersensitivity to the components of the study drugs or their analogs
Known hypersensitivity to any of the study drugs
Known allergy or hypersensitivity to any of the study drugs
Known hypersensitivity to the components of study drugs or analogs of study drugs
Known hypersensitivity to any components of study drugs
Known hypersensitivity to any of the study drugs
Known hypersensitivity to any of the study drugs
Documented hypersensitivity to any of the drugs used in the protocol
Known hypersensitivity to any immunomodulatory drugs (IMiDs), including Grade  rash
Prior history of infusion reactions or hypersensitivity to any of the study drugs
Known anaphylactic or severe hypersensitivity to the study drugs or their analogs
Known anaphylactic or severe hypersensitivity to study drugs or their analogs
Any contraindication or known allergy or hypersensitivity to any study drugs
Known history of hypersensitivity to aromatase-inhibitor drugs
Patient has a known hypersensitivity to the components of study drugs, its analogues, or drugs of similar chemical or biologic composition
Patient has hypersensitivity to any of the components of study drugs.
Known hypersensitivity to any of the study drugs
Known hypersensitivity to any of the study drugs involved
History of hypersensitivity to any of the study drugs or to drugs of similar chemical classes (e.g. monoclonal antibodies, polyclonal gamma globulin, polysorbates)
Known hypersensitivity to any components of the study drugs
Known hypersensitivity or contraindication to study drugs, oxazolidinones, or quinolones.
Subjects with known hypersensitivity to peptide drugs, including LHRH agonists.
Known hypersensitivity to the study drugs
Known hypersensitivity to the study drugs
Known hypersensitivity to any of the study drugs
Patient has a known hypersensitivity to the administration of any prescribed oral or intravenous study medication or metabolite, including but not limited to, a history of hypersensitivity to the drugs or their components, severe renal impairment, severe bone marrow suppression, or systemic infection
